| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/(SICI)1098-2396(199602)22:2<159::AID-SYN8>3.0.CO;2-C |
| P698 | PubMed publication ID | 8787131 |
| P2093 | author name string | Starr MS | |
| P2860 | cites work | Transient abolition of generalized photosensitive epileptic discharge in humans by apomorphine, a dopamine-receptor agonist. | Q54063153 |
| Drugs in management of hyperkinetic and perceptually handicapped children. | Q54349936 | ||
| Dopamine agonist treatment of self-induced pattern-sensitive epilepsy. A case report. | Q54377404 | ||
| Acute and chronic effects of d- and 1-amphetamine on seizure susceptibility in mice. | Q54632709 | ||
| Evidence that LY-141865 specifically stimulates the D-2 dopamine receptor | Q59095560 | ||
| Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine | Q24319813 | ||
| Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics | Q28258681 | ||
| Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy | Q28281986 | ||
| Autoradiographic distribution of the D1 agonist [3H]SKF 38393, in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors | Q28285264 | ||
| Brain areas involved in the catecholamine mediated regulation of electroshock seizure intensity | Q28316501 | ||
| Dopaminergic modulation of pilocarpine-induced motor seizures in the rat: the role of hippocampal dopamine D1 receptors | Q28317564 | ||
| The effects of chronic administration and withdrawal of (+)-amphetamine on seizure threshold and endogenous catecholamine concentrations and their rates of biosynthesis in mice | Q28325321 | ||
| Dopamine D1 and D2 receptors mediate opposite functions in seizures induced by lithium-pilocarpine | Q28326495 | ||
| Dopamine D1 receptor modulation of pilocarpine-induced convulsions | Q28329945 | ||
| Mechanisms underlying modifications in the severity of audiogenic convulsions | Q28330798 | ||
| Changes in convulsion susceptibility of lidocaine by alteration of brain catecholaminergic functions | Q28332900 | ||
| D-2 agonists protect rodents against pilocarpine-induced convulsions by stimulating D-2 receptors in the striatum, but not in the substantia nigra | Q28333573 | ||
| Opposite effects of stimulation of D1 and D2 dopamine receptors on the expression of motor seizures in mouse and rat | Q28334245 | ||
| Seizure promotion and protection by D-1 and D-2 dopaminergic drugs in the mouse | Q28334351 | ||
| Anticonvulsant action of SCH 23390 in the striatum of the rat | Q28334535 | ||
| Seizures after antiemetic treatment with high dose domperidone: report of four cases | Q28366652 | ||
| Effects of apomorphine, ergocornine and piribedil on audiogenic seizures in DBA/2 mice | Q30498874 | ||
| Effect of vigabatrin on striatal dopamine receptors: evidence in humans for interactions of GABA and dopamine systems | Q33591417 | ||
| Dopamine agonists suppress visual-cortical reflex myoclonus | Q33621744 | ||
| The effect of different vigabatrin treatment regimens on CSF biochemistry and seizure control in epileptic patients | Q34396886 | ||
| Differences between light and sound sleepers in the residual effects of nitrazepam | Q34515632 | ||
| Serotonin release as a possible mechanism of reserpine action | Q34537813 | ||
| Dopamine receptor interactions: some implications for the treatment of Parkinson's disease | Q35327584 | ||
| Genetic models of absence epilepsy, with emphasis on the WAG/Rij strain of rats | Q35375456 | ||
| A sustained effect of electroconvulsive shock on the turnover of norepinephrine in the central nervous system of the rat | Q35978390 | ||
| Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia | Q36500321 | ||
| Neurochemical and Behavioral Aspects of Lamotrigine | Q36541033 | ||
| Audiogenic seizures data in mice supporting new theories of biogenic amines mechanisms in the central nervous system | Q36584488 | ||
| Use of cerebrospinal fluid drawn at pneumoencephalography in the study of monoamine metabolism in man. | Q37100232 | ||
| Anatomy, physiology, and pathology of epilepsy | Q37593780 | ||
| Basic mechanisms of focal epilepsies | Q37812753 | ||
| Does kindling model anything clinically relevant? | Q38140927 | ||
| El mouse as a model of focal epilepsy: a review | Q38224881 | ||
| The genetically epilepsy-prone rat. A valuable model for the study of the epilepsies | Q38364250 | ||
| Review: cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel experimental model of intractable epilepsy | Q38612512 | ||
| Reduction in tyrosine hydroxylase activity in the rat amygdala induced by kindling stimulation | Q39207498 | ||
| Monoamine metabolites in the CSF of epileptic patients | Q39258985 | ||
| The substituted benzamides - a novel class of dopamine antagonists | Q39276829 | ||
| Dopaminergic antagonism of L-5-hydroxytryptophan-induced myoclonic jumping behavior | Q39283897 | ||
| Seizure proneness and neurotransmitter uptake | Q39304328 | ||
| D1 dopamine receptor--the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications | Q39487630 | ||
| Hyperprolactinemia and temporal lobe epilepsy in a woman: concomitant and persistent prolactin suppression and temporal lobe epilepsy relief | Q39518569 | ||
| Mechanisms of anticonvulsant drug action. II. Drugs primarily used for absence epilepsy | Q39595015 | ||
| Blockade of photically induced epilepsy by ?dopamine agonist? ergot alkaloids | Q39603035 | ||
| Imipramine in absence and myoclonic-astatic seizures | Q39620032 | ||
| Apomorphine in the evaluation of dopaminergic function in man. | Q39649376 | ||
| Psychoactive agents, seizure production, and sudden death in epilepsy | Q39679821 | ||
| Models for understanding the antagonism between seizures and psychosis | Q39687942 | ||
| Non-Monoamine Oxidase Inhibitor Antidepressants and Epilepsy: A Review | Q39761196 | ||
| Current views of the pathobiochemistry of epilepsy | Q39762150 | ||
| Pharmacological Prophylaxis in the Kindling Model of Epilepsy | Q39863867 | ||
| Brain amines and spontaneous epileptic seizures in the Mongolian gerbil | Q39998185 | ||
| Effects of dopamine D1 and D2 receptor agonists and antagonists on seizures induced by chemoconvulsants in mice | Q42284572 | ||
| Paradoxical facilitation of pilocarpine-induced seizures in the mouse by MK-801 and the nitric oxide synthesis inhibitor L-NAME. | Q42287881 | ||
| Kainic acid induced seizures: neurochemical and histopathological changes | Q42447130 | ||
| Regional effects of sodium valproate on extracellular concentrations of 5-hydroxytryptamine, dopamine, and their metabolites in the rat brain: an in vivo microdialysis study | Q42455719 | ||
| Central dopaminergic transmission is selectively increased in the limbic system of rats chronically exposed to antidepressants. | Q42480079 | ||
| Expression of c-fos protein in the experimental epilepsy induced by pilocarpine | Q42558145 | ||
| Excitatory neuronal responses to dopamine in the cerebral cortex: involvement of D2 but not D1 dopamine receptors | Q42574272 | ||
| Effect of milacemide on extracellular and tissue concentrations of dopamine and 5-hydroxytryptamine in rat frontal cortex | Q42710523 | ||
| In vivo microdialysis of amino acid neurotransmitters in the hippocampus in amygdaloid kindled rat | Q43451812 | ||
| Lesions of noradrenergic neurons in rats with spontaneous generalized non-convulsive epilepsy | Q43509300 | ||
| Magnetic resonance imaging after corpus callosotomy | Q43596977 | ||
| 3H-SCH 23390 binding sites in the rat substantia nigra: evidence for a presynaptic localization and innervation by dopamine | Q43641857 | ||
| Chronic electroconvulsive shock increases D-1 receptor binding in rat substantia nigra | Q43678566 | ||
| Antagonism of the anticonvulsant action of phenytoin, phenobarbital and acetazolamide by 6-hydroxydopamine | Q43682211 | ||
| The relationship between metal ion levels and biogenic amine levels in epileptic mice | Q43732617 | ||
| Forebrain noradrenaline and Metrazol-induced seizures | Q43933298 | ||
| Relationship between kindled myoclonic seizures and feline brain dopamine metabolism | Q43933729 | ||
| Different laminar distributions of dopamine D1 and D2 receptors in the rat hippocampal region | Q44239387 | ||
| Regional effects of MK-801 on dopamine and its metabolites studied by in vivo microdialysis | Q44285736 | ||
| Common dopaminergic mechanism for epileptic photosensitivity in progressive myoclonus epilepsies | Q44330283 | ||
| Brain concentrations and synthesis rates of biogenic amines during chronic cobalt experimental epilepsy in the rat | Q44421617 | ||
| Effect of 6-hydroxydopamine: delayed motor manifestations associated with high mortality in sound-induced seizures in mice | Q44479665 | ||
| Seizure susceptibility and anticonvulsant activity of carbamazepine, diphenylhydantoin and phenobarbital in rats with selective depletions of brain monoamines. | Q44665019 | ||
| Effect of 6-hydroxydopamine pretreatment on spontaneous convulsions induced by barbital withdrawal | Q44679060 | ||
| Brain Noradrenergic Systems as a Prerequisite for Developing Tolerance to Barbiturates | Q44714732 | ||
| Monoaminergic correlates of kindling | Q44755149 | ||
| Drugs modifying dopaminergic activity and behaviour, the EEG and epilepsy in Papio papio | Q44780714 | ||
| Effect of neonatal 6-hydroxydopamine treatment on audiogenic seizures | Q44837464 | ||
| Prevention of sudden cardiac death by the atypical neuroleptic acepromazine following status epilepticus in rats | Q44864786 | ||
| Letter: Effect of lithium carbonate and alpha-methyl-p-tyrosine on audiogenic seizure intensity | Q45152165 | ||
| Inhibition of the anticonvulsant activity of L-dopa by FLA-63, a dopamine- -hydroxylase inhibitor | Q45204855 | ||
| Long-lasting depletion of dopamine in the rat amygdala induced by kindling stimulation | Q46058624 | ||
| In vivo neurochemical effects of electroconvulsive shock studied by microdialysis in the rat striatum | Q46074731 | ||
| The influence of manganese supplementation on seizure onset and severity, and brain monoamines in the genetically epilepsy prone rat. | Q46331143 | ||
| Morphological evidence for a dopaminergic terminal field in the hippocampal formation of young and adult rat. | Q46363591 | ||
| Neurotransmitter changes in guinea-pig brain regions following soman intoxication | Q46916773 | ||
| Brain norepinephrine, dopamine, and 5-hydroxytryptamine concentration abnormalities and their role in the high seizure susceptibility of epileptic chickens | Q47652067 | ||
| Pilocarpine-Induced Convulsions in Rats: Evidence for Muscarinic Receptor-Mediated Activation of Locus Coeruleus and Norepinephrine Release in Cholinolytic Seizure Development | Q47929497 | ||
| Central monoamines and convulsine thresholds in mice and rats | Q47973748 | ||
| Mesolimbic dopaminergic supersensitivity following electrical kindling of the amygdala | Q48119689 | ||
| Effects of chronic haloperidol treatment on amygdaloid seizure generation in cats | Q48153259 | ||
| Levels of catechols in epileptogenic and nonepileptogenic regions of the human brain | Q48153804 | ||
| Striatal dopamine receptor binding in epileptic psychoses | Q48156689 | ||
| The central effects of a novel dopamine agonist | Q48167845 | ||
| Acute effect of some psychotropic drugs on low-frequency amygdaloid kindled seizures | Q48173973 | ||
| A role of the striatum in premotor cortical seizure development | Q48176886 | ||
| MPTP and convulsive responses in rodents | Q48182365 | ||
| Ontogeny of brain catecholamine turnover and susceptibility to audiogenic seizures in DBA/2J mice | Q48192276 | ||
| Excitatory and inhibitory action of dopamine on hippocampal neurons in vitro. Involvement of D2 and D1 receptors | Q48202391 | ||
| Opposing roles of dopamine D1 and D2 receptors in nigral gamma-[3H]aminobutyric acid release? | Q48202565 | ||
| Functional changes in cerebral 5-hydroxytryptamine metabolism in the mouse induced by anticonvulsant drugs | Q40034055 | ||
| Neurotransmitter abnormalities as determinants of seizure susceptibility and intensity in the genetic models of epilepsy | Q40085930 | ||
| Effect of Combined Dopaminergic and GABA-ergic Stimulation on Ouabain-Induced Epileptiform Activity | Q40117293 | ||
| Enhancement of Alcohol Withdrawal Seizures with 6-Hydroxy dopamine | Q40203514 | ||
| Effect of electroconvulsive shock on monoaminergic receptor binding sites in rat brain | Q40233528 | ||
| Effects of reserpine, propranolol, and aminophylline on seizure activity and CNS cyclic nucleotides | Q40299975 | ||
| A Primate Model for Testing Anticonvulsant Drugs | Q40324409 | ||
| Monoamine metabolism during bicuculline-induced epileptic seizures in the rat | Q40695107 | ||
| l-5-Hydroxytryptophan-induced myoclonus in guinea pigs: A model for the study of central serotonin-dopamine interactions | Q40696820 | ||
| Pharmacokinetics and pharmacodynamics of clozapine | Q40886861 | ||
| Effect of intracisternal 6-hydroxydopamine on seizure susceptibility in rats | Q41041815 | ||
| Modulatory role for biogenic amines in the cerebral cortex. Microiontophoretic studies | Q41047023 | ||
| Persistent increases in dopamine D2 receptor mRNA expression in basal ganglia following kindling. | Q41049088 | ||
| Catecholamines released from cerebral cortex in the cat; decrease during sensory stimulation | Q41059902 | ||
| Amino acids, monoamines and audiogenic seizures in genetically epilepsy-prone rats: effects of aspartame | Q41129809 | ||
| The acute convulsant effect of MPTP is dependent on intracerebral MPP+. | Q41139486 | ||
| Effects of chronic electroconvulsive shock on interstitial concentrations of dopamine in the nucleus accumbens | Q41141018 | ||
| Spike-and-wave neocortical patterns in rats: genetic and aminergic control. | Q41204399 | ||
| Long-Term Therapy of Myoclonus and Other Neurologic Disorders with L-5-Hydroxytryptophan and Carbidopa | Q41220570 | ||
| Noradrenaline and 5-hydroxytryptamine release in the hippocampus during seizures induced by hippocampal kindling stimulation: an in vivo microdialysis study | Q41258173 | ||
| MPTP is proconvulsant acutely but has no long-term effect in rodent models of seizure and epilepsy | Q41283565 | ||
| The effects of intracerebroventricularly administered noradnamine and other sympathomimetic amines upon leptazol convulsions in mice | Q41357088 | ||
| Blockade of biogenic amine synthesis: its effect on the responses to leptazol and dexamphetamine in rats | Q41379019 | ||
| Nigral control of hippocampal epilepsy: a dopaminergic hypothesis | Q41410775 | ||
| Effects of acute and chronic carbamazepine administration on apomorphine-elicited stereotypy | Q41470097 | ||
| Potentiation of amygdala kindling in adult or infant rats by injections of 6-hydroxydopamine | Q41492188 | ||
| Turnover kinetics of dopamine and norepinephrine in the forebrain after kindling in rats | Q41515726 | ||
| Abnormalities in Monoamine Levels in the Central Nervous System of the Genetically Epilepsy-Prone Rat | Q41553532 | ||
| Possible involvement of brainstem norepinephrine in pentylenetetrazol convulsions in rats | Q41586850 | ||
| Effects of d-amphetamine and apomorphine in a new animal model of petit mal epilepsy | Q41599718 | ||
| Ischemia-induced seizures and cortical monoamine levels | Q41831490 | ||
| Dopamine agonists and cobalt-induced epilepsy in the rat | Q41908883 | ||
| Inhibition of reflex epilepsy by (+/-)-N-n-propylnorapomorphine | Q41911588 | ||
| Pharmacological characterization of D1 and D2 dopamine receptors in rat limbocortical areas. II. Dorsal hippocampus | Q42202490 | ||
| Behavioural role of dopamine D1 receptors in the reserpine-treated mouse | Q42204063 | ||
| Episodic barrel rotations induced by intrastriatal injection of quinolinic acid in rats. Inhibition by anticonvulsants | Q42204549 | ||
| Dopaminomimetic action of diphenylhydantoin in rat striatum: effect on homovanillic acid and cyclic AMP levels | Q42205051 | ||
| Effects of antiepileptic drugs on absence-like and tonic seizures in the spontaneously epileptic rat, a double mutant rat. | Q42209037 | ||
| Studies on the involvement of dopamine D-1 and D-2 receptors in the anticonvulsant effect of dopamine agonists in various rodent models of epilepsy | Q42222243 | ||
| Comparative assessment of dopamine agonist aporphines as anticonvulsants in two models of reflex epilepsy | Q42248701 | ||
| Activity of two new potent dopaminergic agonists at the striatal and anterior pituitary levels | Q42272141 | ||
| Glutamate-dopamine interactions in the production of pilocarpine motor seizures in the mouse | Q42281604 | ||
| Effects of dopamine D3 receptor agonists on pilocarpine-induced limbic seizures in the rat. | Q42282126 | ||
| Dopaminergic modulation of pilocarpine-induced motor seizures in the rat: the role of hippocampal D2 receptors | Q42284449 | ||
| Disordered dopamine neurotransmission in the striatum of rats undergoing pilocarpine-induced generalized seizures, as revealed by microdialysis | Q42284499 | ||
| The pharmacology of seizures induced by sensitization with low intensity brain stimulation | Q48644973 | ||
| The role of biogenic amines in the reserpine-induced alteration of minimal electroshock seizure thresholds in the mouse | Q48649865 | ||
| Potentiation of leptazol seizures by 6-hydroxydopamine | Q48656503 | ||
| Anticonvulsant effects of ipsilateral but not contralateral microinjections of the dopamine D2 agonist LY 171555 into the nucleus accumbens of amygdala-kindled rats | Q48690077 | ||
| Modulation of low calcium induced field bursts in the hippocampus by monoamines and cholinomimetics | Q48690832 | ||
| Cholinomimetics produce seizures and brain damage in rats | Q48704604 | ||
| Enhancement of audiogenic seizure by 6-hydroxydopamine | Q48718562 | ||
| The concentration of homovanillic and 5-hydroxyindoleacetic acids in ventricular and lumbar CSF. Studies in patients with extrapyramidal disorders, epilepsy, and other diseases | Q48719108 | ||
| Effects of L-tryptophan, L-3, 4, dihydroxyphenylalanine and tranylcypromine on the electroencephalogram and on photically induced epilepsy in the baboon, Papio papio | Q48725598 | ||
| Bicuculline-induced neocortical epileptiform foci and the effects of 6-hydroxydopamine in developing rats | Q48727921 | ||
| Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study | Q48738084 | ||
| Time-drug modulations of photically evoked after-discharge patterns | Q48756132 | ||
| Effects of chronic treatment with haloperidol and methamphetamine on hippocampal kindled seizures in the cat. | Q48756962 | ||
| Monoamine turnover in the brain of mice during development of tolerance to the anticonvulsant effect of clonazepam | Q48757024 | ||
| SCH 23390—The first selective dopamine D-1 antagonist | Q48775956 | ||
| Dopaminergic control of feline hippocampal epilepsy: a nigro hippocampal pathway | Q48795133 | ||
| The importance of the caudate nucleus in the control of convulsive activity in the amygdaloid complex and the temporal cortex of the cat. | Q48818706 | ||
| Anticonvulsant effect of striatal dopamine D2 receptor stimulation: Dependence on cortical circuits? | Q48824970 | ||
| Studies on the pharmacology of d-amphetamine on maximal electroconvulsive seizure in young chicks | Q48830345 | ||
| Dopa reversal of reserpine enhancement of audiogenic seizure susceptibility in mice | Q48841013 | ||
| Substantia nigra: site of anticonvulsant activity mediated by gamma-aminobutyric acid | Q48858993 | ||
| Catecholamine level in cerebrospinal fluid of epileptics | Q48888079 | ||
| Inhibition of low calcium induced epileptiform discharges in the hippocampus by dopamine D1 receptor agonist, SKF 38393. | Q48895469 | ||
| Opposite changes of dopamine turnover in prefrontal cortex and nucleus accumbens after amygdaloid kindling | Q48898561 | ||
| Effects of the Convulsant Methionine Sulfoximine on Striatal Dopamine Metabolism | Q48920419 | ||
| Effect of intraventricular administration of calcium on the lowering of brain dopamine level in epileptic mice | Q48922873 | ||
| Neurotransmitter receptors in adult tottering (tg/tg) mice | Q48944426 | ||
| Transmitter release in hippocampal slices from rats with limbic seizures produced by systemic administration of kainic acid | Q48964555 | ||
| Substantia nigra-mediated anticonvulsant action: a possible role of a dopaminergic component | Q48972427 | ||
| Age-dependent reduction in maximum electroshock convulsive threshold associated with decreased concentrations of brain monoamines | Q48984989 | ||
| Evidence for dopamine as a transmitter in dorsal hippocampus | Q49016114 | ||
| Enzyme activities in the central nervous system of the epilepsy-prone rat. | Q49019768 | ||
| Catecholaminergic systems and amygdala kindling development. Effects of bilateral lesions of substantia nigra dopaminergic or locus coeruleus noradrenergic neurones | Q49087985 | ||
| Increased paroxysmal activity of partial seizures in man by apomorphine | Q49124584 | ||
| Neuropharmacological analysis of handling-induced seizures in gerbils | Q49147858 | ||
| The convulsive effects of dopamine sulfate conjugates in rat brain | Q49154427 | ||
| Experimental evidence for the existence of an extrarhinencephalic control of the activity of the cobalt rhinencephalic epileptogenic focus. Part 1. The role played by the caudate nucleus. | Q51161238 | ||
| Spontaneous epileptic seizures and electroencephalographic changes in the course of phenothiazine therapy | Q51206239 | ||
| Multiple response of visual cortex of the rat to photic stimulation. | Q51296718 | ||
| Depression by reserpine of the noradrenaline concentration in the hypothalamus of the cat. | Q51331651 | ||
| Thalamic deficiency in norepinephrine release detected via intracerebral microdialysis: a synaptic determinant of seizure predisposition in the genetically epilepsy-prone rat. | Q51669236 | ||
| Kainic acid-induced seizures: potentiation by alpha-methyl-p-tyrosine. | Q51750138 | ||
| Noradrenergic mechanisms in gamma-hydroxybutyrate-induced seizure activity. | Q51792001 | ||
| The effect of some anti-epilepsy drugs on enhancement of the monoamine-mediated behavioural responses following the administration of electroconvulsive shocks to rats | Q51865796 | ||
| Inhibition of amygdaloid kindling by chronic pretreatment with cocaine or methamphetamine. | Q51873778 | ||
| Mental state and temporal lobe epilepsy. A correlative account of 100 patients treated surgically. | Q52119564 | ||
| Treatment of two hundred disturbed psychotics with reserpine. | Q52172057 | ||
| Biological antagonism and epileptic psychosis. | Q52405680 | ||
| Electrical stimulation of the kindled hippocampus briefly increases extracellular dopamine in the nucleus accumbens. | Q52918584 | ||
| The effects of apomorphine, (+)-amphetamine and L-dopa on maximal electroshock convulsions--a comparative study in the rat and mouse. | Q53814776 | ||
| Spontaneous recurrent seizures in rats: amino acid and monoamine determination in the hippocampus | Q48210073 | ||
| Bimodal effects of dopamine D2 receptor agonists on zero Mg(2+)-induced epileptiform activity in the rat cingulate cortex slice | Q48226620 | ||
| Dopamine agonists and audiogenic seizures: The relationship between protection against seizures and changes in monoamine metabolism | Q48232213 | ||
| ECS-induced dopamine release: effects of electrode placement, anticonvulsant treatment, and stimulus intensity | Q48236211 | ||
| The role of dopamine in behavioral supersensitivity to muscarinic antagonists following cholinesterase inhibition | Q48265519 | ||
| Electrical kindling of rats treated discontinuously or continuously with haloperidol | Q48268544 | ||
| Kindling induced changes in EEG recorded during stimulation from the site of stimulation: collapse of GABA-mediated inhibition and onset of rhythmic synchronous burst | Q48269623 | ||
| Suppression of penicillin-induced epileptiform activity by noxious stimulation: mediation by 5-hydroxytryptamine | Q48274804 | ||
| Is c-Jun involved in nerve cell death following status epilepticus and hypoxic-ischaemic brain injury? | Q48277117 | ||
| Determination of neurotransmitter release into the caudate nucleus during convulsions induced by pentylenetetrazole using in vivo differential pulse voltammetry | Q48287282 | ||
| Decreased dopamine and increased norepinephrine levels in the spontaneously epileptic rat, a double mutant rat. | Q48288579 | ||
| Substance P antagonists in substantia nigra are anticonvulsant | Q48299053 | ||
| Effect of carbamazepine on dopamine release and reuptake in rat striatal slices | Q48303217 | ||
| Determination of Amino Acids and Monoamine Neurotransmitters in Caudate Nucleus of Seizure‐Resistant and Seizure‐Prone BALB/c Mice | Q48317971 | ||
| Endogenous dopaminergic asymmetry affects development of seizures kindled in the rat amygdala | Q48325462 | ||
| Age- and seizure-related changes in noradrenaline and dopamine in several brain regions of epileptic El mice | Q48334471 | ||
| Nicotine-induced convulsions in cats and central nicotinic receptors | Q48341073 | ||
| Evidence for dopamine receptors mediating sedation in the mouse brain | Q48344344 | ||
| Unilateral peri-substantia nigra catecholaminergic lesion and amygdala kindling | Q48355455 | ||
| Spontaneous paroxysmal activity induced by zero magnesium and bicuculline: suppression by NMDA antagonists and GABA mimetics | Q48365914 | ||
| Effects of drugs modifying brain levels of catecholamines on photically induced epilepsy in Papio papio | Q48366610 | ||
| The effects of desipramine, zimelidine, electroconvulsive treatment and lithium on rat brain biogenic amines: a comparison with peripheral changes | Q48367605 | ||
| Ergot alkaloids as dopamine agonists: comparison in two rodent models | Q48383617 | ||
| Seizure promotion by D1 agonists does not correlate with other dopaminergic properties | Q48386065 | ||
| Evidence for a functional role of dopamine type-1 (D-1) receptors in the substantia nigra of rats | Q48386174 | ||
| Neuropharmacological modification of central catecholamines: effects on pinealectomy-induced convulsions | Q48388239 | ||
| Audiogenic seizures: Relation to age and mechanisms of monoamine neurotransmission | Q48392582 | ||
| Antiepileptic effects of CNK-602A, a novel thyrotropin-releasing hormone analog, on absence-like and tonic seizures of spontaneously epileptic rats | Q48406787 | ||
| Effects of zonisamide on extracellular levels of monoamine and its metabolite, and on Ca2+ dependent dopamine release | Q48411571 | ||
| Effect of amygdaloid kindling on [3H]dopamine and [14C]acetylcholine release from rat prefrontal cortex and striatal slices | Q48420819 | ||
| Effects of emotional stress on E1-mouse convulsions, and their biochemical background | Q48424610 | ||
| Amygdala kindling in juvenile rats following neonatal administration of 6-hydroxydopamine | Q48431737 | ||
| Amygdala kindling does not alter the N-methyl-D-aspartate receptor-channel complex which modulates dopamine release in the rat striatum and amygdala | Q48445794 | ||
| Effects of pentylenetetrazol-induced seizures on dopamine and norepinephrine levels and on glucose utilization in various brain regions of the developing rat | Q48450080 | ||
| Convulsive thresholds and severity and the anticonvulsant effect of phenobarbital and phenytoin in adult rats administered 6-hydroxydopamine or 5,7-dihydroxytryptamine during postnatal development | Q48457544 | ||
| Regional distribution of tyrosine, tryptophan, and their metabolites in the brain of epileptic El mice | Q48462949 | ||
| Catecholamine regulation of neocortical spindling in DBA/2 mice | Q48467653 | ||
| Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486 | Q48478818 | ||
| Reduced cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in children with epilepsy | Q48493931 | ||
| The relative significance of norepinephrine, dopamine and 5-hydroxytryptamine in electroshock seizure in the rat | Q48507982 | ||
| Potentiation of amygdaloid kindling and metrazol-induced seizures by 6-hydroxydopamine in rats | Q48520563 | ||
| The influence of dopamine on epileptiform burst activity in hippocampal pyramidal neurons | Q48522261 | ||
| Effects of diisopropyl phosphorofluoridate on acetylcholine, cholinesterase and catecholamines of several parts of rabbit brain | Q48544392 | ||
| Monosodium L-glutamate-induced convulsions--II. Changes in catecholamine concentrations in various brain areas of adult rats | Q48544972 | ||
| Alteration of seizures resulting from pinealectomy in the rat after neonatal treatment with 6-hydroxydopamine | Q48560431 | ||
| Pharmacological effects of 1,3-dimethyl-5-aminoadamantane, a new adamantane derivative | Q48564786 | ||
| Effects of aging on signal transmission and transduction systems in the gerbil brain: morphological and autoradiographic study | Q48594894 | ||
| Pentylenetetrazol convulsions and brain catecholamine turnover rate in rats and mice receiving diphenylhydantoin or benzodiazepines | Q48620580 | ||
| Effect of increments in the concentration of dopamine in the central nervous system on audiogenic seizures in DBA/2J mice | Q48631490 | ||
| Effects of atropine, reserpine, 6-hydroxydopamine, and handling on seizure development in the rat. | Q48641689 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 159-194 | |
| P577 | publication date | 1996-02-01 | |
| P1433 | published in | Synapse | Q7662025 |
| P1476 | title | The role of dopamine in epilepsy | |
| P478 | volume | 22 |
| Q28588180 | Absence of dopamine D4 receptors results in enhanced reactivity to unconditioned, but not conditioned, fear |
| Q49159401 | Action of 4-aminopyridine on extracellular amino acids in hippocampus and entorhinal cortex: a dual microdialysis and electroencehalographic study in awake rats |
| Q44335608 | Amantadine-induced multiple spike waves on an electroencephalogram of a schizophrenic patient |
| Q48061276 | Ameliorative effect of Asparagus racemosus root extract against pentylenetetrazol-induced kindling and associated depression and memory deficit |
| Q44026215 | Amino acid and monoamine alterations in the cerebral cortex and hippocampus of mice submitted to ricinine-induced seizures. |
| Q44893909 | Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D and 5-HT receptors |
| Q35236134 | Anticonvulsant drugs in bipolar disorder. |
| Q64230856 | Anticonvulsant effect of Sphaeranthus flower extracts in mice |
| Q34091982 | Anticonvulsant preclinical profile of CHF 3381: dopaminergic and glutamatergic mechanisms |
| Q44026270 | Anticonvulsive activity of Butea monosperma flowers in laboratory animals |
| Q34570582 | Atypical antipsychotics and serotoninergic antidepressants in patients with epilepsy: pharmacodynamic considerations |
| Q33803075 | Behavioral, psychotic, and anxiety disorders in epilepsy: etiology, clinical features, and therapeutic implications |
| Q34023838 | Behaviors induced or disrupted by complex partial seizures |
| Q43581345 | Biogenic amines in the human neocortex in patients with neocortical and mesial temporal lobe epilepsy: identification with in situ microvoltammetry |
| Q46533519 | Catatonia, neuroleptics and brain damage--a case report |
| Q35151927 | Cell signaling underlying epileptic behavior. |
| Q43785281 | Changes in AMPA receptor binding and subunit messenger RNA expression in hippocampus and cortex in the pentylenetetrazole-induced 'kindling' model of epilepsy |
| Q32065087 | Changes in striatal electroencephalography and neurochemistry induced by kainic acid seizures are modified by dopamine receptor antagonists |
| Q51961608 | Characteristics of postictal psychosis in a psychiatric center. |
| Q34747009 | Characterization of a dopamine transporter polymorphism and behavior in Belgian Malinois |
| Q46011247 | Characterization of the anticonvulsant activity of doxepin in various experimental seizure models in mice. |
| Q48486472 | Compensatory Changes in the Brain Dopaminergic System of WAG/Rij Rats Genetically Predisposed to Absence Epilepsy |
| Q37732350 | Correlation of 3-mercaptopropionic acid induced seizures and changes in striatal neurotransmitters monitored by microdialysis |
| Q60649680 | Cortical catecholamine changes and seizures induced by 4-aminopyridine in awake rats, studied with a dual microdialysis-electrical recording technique |
| Q48441390 | Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy: an [18F]fallypride PET study |
| Q38029816 | Do the basal ganglia inhibit seizure activity in temporal lobe epilepsy? |
| Q26864383 | Dopamine D1 receptor signaling: does GαQ-phospholipase C actually play a role? |
| Q37212440 | Dopamine D1 vs D5 receptor-dependent induction of seizures in relation to DARPP-32, ERK1/2 and GluR1-AMPA signalling |
| Q28513386 | Dopamine D4 receptor-deficient mice display cortical hyperexcitability |
| Q35587368 | Dopamine and the development of executive dysfunction in autism spectrum disorders |
| Q45094697 | Dopamine enhances spatiotemporal spread of activity in rat prefrontal cortex |
| Q73011751 | Dopamine in the striatum modulates seizures in a genetic model of absence epilepsy in the rat |
| Q43814491 | Dopamine inhibition of evoked IPSCs in rat prefrontal cortex |
| Q61452627 | Dopamine levels in human tear fluid |
| Q48258175 | Dopamine modulation of membrane and synaptic properties of interneurons in rat cerebral cortex |
| Q48225729 | Dopaminergic modulation of local network activity in rat prefrontal cortex |
| Q48467168 | Dopaminergic modulation of low-Mg²⁺-induced epileptiform activity in the intact hippocampus of the newborn mouse in vitro |
| Q28754545 | Dysfunctional GABAergic inhibition in the prefrontal cortex leading to "psychotic" hyperactivation |
| Q57042612 | EEG background delta activity in temporal lobe epilepsy: correlation with volumetric and spectroscopic imaging |
| Q52092227 | Effect of γ-ethyl-γ-phenyl-butyrolactone (EFBL), anticonvulsant and hypnotic drug, on mouse brain catecholamine levels. |
| Q28369479 | Effects of diazepam on extracellular brain neurotransmitters in pilocarpine-induced seizures in rats |
| Q43698568 | Electrophysiological and pharmacological characteristics of two types of spike-wave discharges in WAG/Rij rats |
| Q34236048 | Endogenous melatonin and epileptogenesis: facts and hypothesis |
| Q48654701 | Enhancement of basal and pentylenetetrazol (PTZ)-stimulated dopamine release in the brain of freely moving rats by PTZ-induced kindling |
| Q37725946 | Epilepsy in the elderly: Special considerations and challenges |
| Q37818528 | Epilepsy in the elderly: facts and challenges |
| Q26743786 | Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review |
| Q48343539 | Epilepsy, parkinsonism, and neuroleptic malignant syndrome in a child. |
| Q48627048 | Epileptiform discharge induced by 4-aminopyridine in magnesium-free medium in neocortical neurons: physiological and pharmacological characterization |
| Q48048624 | Evidence in support of using a neurochemistry approach to identify therapy for both epilepsy and associated depression |
| Q97593267 | Flexible, diamond-based microelectrodes fabricated using the diamond growth side for neural sensing |
| Q35700485 | Functional MRI during Hippocampal Deep Brain Stimulation in the Healthy Rat Brain |
| Q42551576 | Hyperactivity and behavioral seizures in rodents following treatment with the dopamine D1 receptor agonists A-86929 and ABT-431. |
| Q48294528 | Ictal dystonia and secondary generalization in temporal lobe seizures: a video-EEG study |
| Q46536791 | In vivo modulatory action of extracellular glutamate on the anticonvulsant effects of hippocampal dopamine and serotonin |
| Q44298264 | Influence of dopamine on ventrolateral thalamic inputs in cat motor cortex |
| Q44154796 | Interaction of stress and noradrenergic drugs in the control of picrotoxin-induced seizures |
| Q28570454 | Involvement of the somatostatin-2 receptor in the anti-convulsant effect of angiotensin IV against pilocarpine-induced limbic seizures in rats |
| Q36495219 | Kainic acid-induced seizures modulate Akt (SER473) phosphorylation in the hippocampus of dopamine D2 receptor knockout mice. |
| Q36653977 | MDMA and seizures: a dangerous liaison? |
| Q48387002 | Mechanisms and functional significance of a slow inhibitory potential in neurons of the lateral amygdala |
| Q62869023 | Monoamine neurotransmitters in resected hippocampal subparcellations from neocortical and mesial temporal lobe epilepsy patients: in situ microvoltammetric studies |
| Q28074736 | Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs |
| Q30417022 | Music and epilepsy: a critical review |
| Q30376992 | Music therapy as a non-pharmacological treatment for epilepsy. |
| Q44212251 | Mutant Taiep rats exhibit an increase in D1 binding in basal ganglia |
| Q28379065 | NMDA receptor-mediated pilocarpine-induced seizures: characterization in freely moving rats by microdialysis |
| Q28505429 | Neuroprotective role of dopamine against hippocampal cell death |
| Q34192415 | On the role of prefrontal cortex glutamate for the antithetical phenomenology of obsessive compulsive disorder and attention deficit hyperactivity disorder |
| Q26778466 | PET studies in epilepsy |
| Q30703243 | Partial epilepsy with pericentral spikes: a new familial epilepsy syndrome with evidence for linkage to chromosome 4p15. |
| Q33748935 | Pharmacological and environmental determinants of relapse to cocaine-seeking behavior |
| Q36205868 | Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interface. |
| Q30819017 | Physiological bases of the K+ and the glutamate/GABA hypotheses of epilepsy |
| Q42464322 | Presynaptic inhibition by dopamine of a discrete component of GABA release in rat substantia nigra pars reticulata |
| Q43963699 | Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats |
| Q44731128 | Psychoneurochemical investigations to reveal neurobiology of memory deficit in epilepsy |
| Q36257859 | Reduced D2/D3 Receptor Binding of Extrastriatal and Striatal Regions in Temporal Lobe Epilepsy |
| Q41843711 | Regulation of circuits and excitability: implications for epileptogenesis |
| Q48648016 | Repeated stimulation of dopamine D1-like receptor and hyperactivation of mTOR signaling lead to generalized seizures, altered dentate gyrus plasticity, and memory deficits. |
| Q33974889 | Rhythm and blues: animal models of epilepsy and depression comorbidity |
| Q31679791 | SCH 23390 affords protection against soman-evoked seizures in the freely moving guinea-pig: a concomitant neurochemical, electrophysiological and behavioural study |
| Q34519671 | SCH 23390: the first selective dopamine D1-like receptor antagonist. |
| Q30400003 | SKF-83959 is not a highly-biased functionally selective D1 dopamine receptor ligand with activity at phospholipase C |
| Q46375537 | Serotonin hyperinnervation abolishes seizure susceptibility in Otx2 conditional mutant mice |
| Q57000032 | The Synergistic Effect of Raloxifene, Fluoxetine, and Bromocriptine Protects Against Pilocarpine-Induced Status Epilepticus and Temporal Lobe Epilepsy |
| Q42462002 | The role of basal ganglia in the control of generalized absence seizures. |
| Q34734993 | The role of catecholamines in seizure susceptibility: new results using genetically engineered mice |
| Q38162732 | The role of different serotonin receptor subtypes in seizure susceptibility. |
| Q37176694 | The role of dopamine signaling in epileptogenesis |
| Q26801864 | The role of dopaminergic and serotonergic systems in neurodevelopmental disorders: a focus on epilepsy and seizure susceptibility |
| Q38647610 | The role of the basal ganglia in the control of seizure |
| Q44514438 | The significance of increase in striatal D(2) receptors in epileptic EL mice |
| Q43070407 | Time course of changes in the concentrations of monoamines in the brain structures of pentylenetetrazole-kindled rats |
| Q42511312 | Up-regulation of D3 dopaminergic receptor mRNA in the core of the nucleus accumbens accompanies the development of seizures in a genetic model of absence-epilepsy in the rat. |
Search more.